[WEBCAST] The Global Race To Develop Vaccines and Treatments for COVID-19VIEW EVENT DETAILS
In partnership with Asia Society Hong Kong
This program has taken place. Find the event recap and program video recording here »
Epidemiologists have reported that a vaccine for COVID-19 will take 12-18 months to develop — and that is aspirational. On average, it takes 5-10 years and billions of dollars for a vaccine to reach the final approval to enter the market. The record so far is for the mumps vaccine, which took approximately four years from development to licensing. The vaccine development process includes three sequential phases of testing — a timeline that can be shortened but with some risk, as certain questions about COVID-19 remain unanswered before human testing, such as whether a person who has been infected with COVID-19 can be reinfected. In the meantime, there may be other technologies and innovations developed to treat the virus, including convalescent plasma therapy (transfusion of antibodies from a recovered patient) and anti-virals such as remdesivir, which has shown promise in reducing time to recovery for people hospitalized with advanced COVID-19.
Asia Society at Home
How do we manage our expectations regarding the development of the vaccine and other treatments? Where are we in the process? Join Asia Society Hong Kong and the Texas Center as experts discuss the global race to develop vaccines and treatments for COVID-19.
Thursday, May 28, 2020
8 p.m. CT — Moderated Discussion
8:30 p.m. CT — Questions welcome via YouTube Live and Facebook Live
About the Speakers
Professor Honglin Chen graduated from Xiamen University in 1983 with BSc in Biology and completed his PhD study at the University of Hong Kong in 1992, working on pathogenesis of Epstein-Barr virus (EBV) in nasopharyngeal carcinoma (NPC). He went on to continue his post-doctoral research on tumor virus at John Hopkins University School of Medicine in 1997. Professor Chen re-joined the University of Hong Kong in 2003 and has since expanded his research scopes to RNA viruses including emerging influenza and coronaviruses. He has since established several research programs which focus on studying molecular determinants for cross species of avian influenza viruses and coronavirus. His research on the NS1 protein of influenza virus has led to the establishment of a unique DelNS1 live attenuated influenza vaccine platform which can be used to develop vaccines for other viruses.
Dr. John P. Cooke is the Joseph C. "Rusty" Walter and Carole Walter Looke Presidential Distinguished Chair of the Department of Cardiovascular Sciences, the Director of the Center for Cardiovascular Regeneration, and Director of the RNA Therapeutics Program at the Houston Methodist Research Institute.The focus of his research is on regenerative medicine. His research has generated 35 patents, and he has founded 4 biotechnology companies. Currently, his group is rejuvenating human cells with RNA encoding human telomerase, and has developed cGMP process for mRNA synthesis, purification, validation and delivery. With respect to mRNA delivery, nanoparticle strategies are being employed; the combination of effective nanoparticle delivery will be transformative for the field of mRNA Therapeutics. During the COVID crisis, he has turned his group toward generating an RNA vaccine against SARS-CoV-2.
Dr. Cooke trained in cardiovascular medicine and obtained a Ph.D. in physiology at the Mayo Clinic. He was then recruited to Harvard Medical School as an assistant professor of medicine. In 1990, he was recruited to Stanford University to spearhead the program in vascular biology and medicine as Professor in the Division of Cardiovascular Medicine, and served as associate director of the Stanford Cardiovascular Institute until his recruitment to Houston Methodist in 2013. He has published over 600 research papers, position papers, reviews, book chapters, and patents in the arena of cardiovascular medicine and biology with >30,000 citations. He has served on committees of the American Heart Association, American College of Cardiology, Society for Vascular Medicine, and the National Heart, Lung and Blood Institute, and has served as president of the Society for Vascular Medicine.
About the Moderator
Edward “Eddie” R. Allen is a co-founder and Senior Partner of Eagle Global Advisors, an investment advisory firm based in Houston, Texas. He serves on the management committee and all investment committees of the firm. In addition to serving as a co-manager of the Eagle MLP Strategy Fund, he is a portfolio manager for a variety of institutional and high net worth clients. Eddie is a co-creator of many of the portfolio strategies and proprietary investment management tools of the firm.Eddie received a Ph.D. in Economics from the University of Chicago and his B.S.E. in Engineering from Princeton University.
Eddie holds the Chartered Financial Analyst (CFA) designation and is also a member the CFA Society of Houston. Before entering the investment advisory business, Eddie served as an Assistant Professor of Economics at the University of Houston.Eddie currently serves as Chairman of the Asia Society Texas Center and is on the board of the Asia Society Global organization. He also currently serves on the boards of The Menil Collection and The Chinquapin School. He is a past board member of St. John’s School and past Chair and President of the Contemporary Arts Museum Houston.
Asia Society hosts today's leading voices, providing commentary on events in news, society, and culture. Opinions expressed do not necessarily reflect Asia Society views.
Asia Society Texas Center Business & Policy Programs, Endowed by
Business and Policy programs at Asia Society Texas Center are presented by Bank of America, Muffet Blake, ConocoPhillips, ExxonMobil, United Airlines, and Wells Fargo. Major support comes from Nancy C. Allen, Chinhui Juhn and Eddie Allen, Nancy Pollok Guinee, and Mary Lawrence Porter, as well as The Brown Foundation, Inc. and Houston Endowment. Additional funding is provided by the Friends of Asia Society Texas Center, a dedicated group of individuals and organizations committed to bringing the best in public programming.
Business & Policy Presenting Sponsors
About Asia Society at Home
Though Asia Society is temporarily closed, we are dedicated to continuing our mission of building cross-cultural understanding and uplifting human connectivity. Using digital tools, we bring you content for all ages and conversations that matter, in order to spark curiosity about Asia and to foster empathy.
About Asia Society Texas Center
With 13 locations throughout the world, Asia Society is the leading educational organization promoting mutual understanding and strengthening partnerships among the peoples, leaders, and institutions of Asia and West. Asia Society Texas Center executes the global mission with a local focus, enriching and engaging the vast diversity of Houston through innovative, relevant programs in arts and culture, business and policy, education, and community outreach.
More from Asia Society
For event details visit https://asiasociety.org/texas/events/webcast-global-race-develop-vaccines-and-treatments-covid-19 For event details visit https://asiasociety.org/texas/events/webcast-global-race-develop-vaccines-and-treatments-covid-19